Lucinda buys IVE 85.18: Traders will gage the health of the U.S. employment sector to gage when the Federal Reserve may raise interest rates.

The iShares NASDAQ Biotechnology Index (ETF) (IBB) slipped another 2.85% in the first 90 minutes of trading. The Nasdaq cratered another 1.56%, while the S&P 500 was off 1.25%. Biotech stocks continue to plunge as concerns about high valuations and proposed price controls rattle investors. Market Selloff: The Dow Jones Industrial Average slumped another 148 points as healthcare stocks continued to selloff over concerns in the biotech sector. Get updates in your Facebook news feed. Business activity gained at the slowest pace in three-months, as entrepreneurs became less confident in the economy's prospects.


Suellen:
All three indexes closed down for the week.

Tu:
Biotechs dragged the Nasdaq lower and the S&P 500 dipped into the red, while the Dow was held afloat mostly by an 8% rally in Nike shares.

Neely:
PKW was able to achieve higher returns than VLUE during rising markets and had a more controlled downward movement during falling markets.

Tomika:
VLUE is primarily invested in IT, financial, and healthcare companies.

Onie:
Value-style investing helps a fund identify stocks that have a strong potential for capital appreciation.

Cindie:
It uses value-style investing, mimicking the investment results of its index, the MSCI USA Enhanced Value Index.

Travis:
Each time the index recovered the loss within about a month.

Theresa:
The Nasdaq biotech gauge saw five pullbacks of more than 6.6 percent in the 14 months leading up to the market-wide correction in late August.

Kaye:
Valeant Pharmaceuticals International Inc., up 52 percent in 2015, has announced 10 acquisitions this year.

Kanisha:
The biotech ETF, which tracks the Nasdaq index, is still up 9.7 percent this year, outperforming the S&P health-care index by 8.3 percentage points.

S&P 500 Value Index Ishares (AMEX:IVE)
//stockhand.net/us/?q=amex%3Aive&id=637442